Influence of polyvascular disease on clinical outcome in patients undergoing transcatheter aortic valve implantation via transfemoral access.
Masahiro YamawakiYosuke HondaKenji MakinoTakahide NakanoYasunori IidaFumiaki YashimaHiroshi UenoKazuki MizutaniMinoru TabataNorio TadaKensuke TakagiFutoshi YamanakaToru NaganumaYusuke WatanabeMasanori YamamotoShinichi ShiraiKentaro Hayashidanull nullPublished in: PloS one (2021)
The increased prevalence of concomitant atherosclerotic VB diseases before TF-TAVI may increase the rates of in-hospital complications and 2-year cardiovascular death. Given the higher rate of mortality in patients with PVD undergoing TF-TAVI, future studies focusing on medical therapy are needed to reduce long-term cardiovascular events in this high-risk subset.
Keyphrases
- transcatheter aortic valve implantation
- cardiovascular events
- patients undergoing
- aortic valve
- aortic valve replacement
- risk factors
- coronary artery disease
- aortic stenosis
- healthcare
- cardiovascular disease
- transcatheter aortic valve replacement
- current status
- ejection fraction
- case control
- type diabetes
- emergency department
- heart failure
- adverse drug
- left ventricular
- bone marrow
- drug induced